Roger Nitsch

Person

Zumikon, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Human anti-SOD1 antibodies
- Patent number 11,352,441
- Issue date Jun 7, 2022
- Neurimmune Holding AG
- Fabio Montrasio
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
TDP-43 specific binding molecules
- Patent number 11,091,540
- Issue date Aug 17, 2021
- Biogen International Neuroscience GmbH
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of providing patient specific immune response in amyloidoses...
- Patent number 10,874,725
- Issue date Dec 29, 2020
- New York University
- Karsten Henco
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human anti-alpha-synuclein antibodies
- Patent number 10,703,808
- Issue date Jul 7, 2020
- Biogen International Neuroscience GmbH
- Andreas Weihofen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-SOD1 antibodies
- Patent number 10,344,097
- Issue date Jul 9, 2019
- Neurimmune Holding AG
- Fabio Montrasio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-alpha synuclein binding molecules
- Patent number 10,301,381
- Issue date May 28, 2019
- Biogen International Neuroscience GmbH
- Andreas Weihofen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TDP-43 specific binding molecules
- Patent number 10,259,866
- Issue date Apr 16, 2019
- Biogen International Neuroscience GmbH
- Roger Nitsch
- G01 - MEASURING TESTING
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 10,202,445
- Issue date Feb 12, 2019
- University of Zurich
- Roger Nitsch
- G01 - MEASURING TESTING
Information Patent Grant
Methods of treating Alzheimer's disease
- Patent number 10,131,708
- Issue date Nov 20, 2018
- University of Zurich
- Roger Nitsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-alpha synuclein binding molecules
- Patent number 9,975,947
- Issue date May 22, 2018
- Biogen International Neuroscience GmbH
- Andreas Weihofen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-alpha-synuclein antibodies
- Patent number 9,896,504
- Issue date Feb 20, 2018
- Biogen International Neuroscience GmbH
- Andreas Weihofen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 9,828,420
- Issue date Nov 28, 2017
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 9,670,272
- Issue date Jun 6, 2017
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-tau antibodies
- Patent number 9,605,059
- Issue date Mar 28, 2017
- Biogen International Neuroscience GmbH
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TDP-43 specific binding molecules
- Patent number 9,587,014
- Issue date Mar 7, 2017
- Biogen International Neuroscience GmbH
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-α synuclein binding molecules
- Patent number 9,580,493
- Issue date Feb 28, 2017
- Biogen International Neuroscience GmbH
- Andreas Weihofen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of providing patient specific immune response in amyloidoses...
- Patent number 9,370,531
- Issue date Jun 21, 2016
- New York University
- Karsten Henco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-SOD1 antibodies
- Patent number 9,283,271
- Issue date Mar 15, 2016
- Neurimmune Holding AG
- Fabio Montrasio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies against the beta-amyloid peptide
- Patent number 9,273,126
- Issue date Mar 1, 2016
- Delenex Therapeutics AG
- Stefan Ewert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-alpha-synuclein antibodies
- Patent number 8,940,276
- Issue date Jan 27, 2015
- Biogen Idec International Neuroscience GmbH
- Andreas Weihofen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human anti-tau antibodies
- Patent number 8,940,272
- Issue date Jan 27, 2015
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 8,906,367
- Issue date Dec 9, 2014
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal human tumor-specific antibody
- Patent number 8,519,106
- Issue date Aug 27, 2013
- University of Zurich
- Christoph Esslinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies against the β-amyloid peptide
- Patent number 8,323,647
- Issue date Dec 4, 2012
- Delenex Therapeutics AG
- Stefan Ewert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgenic animal model for alzheimer's disease
- Patent number 8,022,268
- Issue date Sep 20, 2011
- The University of Zurich
- Jan Grimm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inducing neurofibrillary tangles in transgenic mice expressing a mu...
- Patent number 7,550,648
- Issue date Jun 23, 2009
- Universitat Zurich
- Jürgen Götz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Muscarinic M1 agonist as an inhibitor of beta-amyloid (Aβ40...
- Patent number 6,573,276
- Issue date Jun 3, 2003
- Boehringer Ingelheim Pharma KG
- Christoph Hock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Human Anti-SOD1 Antibodies
- Publication number 20240254256
- Publication date Aug 1, 2024
- NEURIMMUNE HOLDING AG
- Fabio Montrasio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVI...
- Publication number 20230242624
- Publication date Aug 3, 2023
- Neurimmune AG
- Stefan MOESE
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20220403011
- Publication date Dec 22, 2022
- University of Zurich
- Roger NITSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-BETA-AMYLOID ANTIBODY FOR TREATING ALZHEIMER'S DISEASE
- Publication number 20220372123
- Publication date Nov 24, 2022
- Biogen MA Inc.
- Samantha Budd Haeberlein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Anti-SOD1 Antibodies
- Publication number 20220267471
- Publication date Aug 25, 2022
- NEURIMMUNE HOLDING AG
- Fabio Montrasio
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES...
- Publication number 20210361754
- Publication date Nov 25, 2021
- NEW YORK UNIVERSITY
- Karsten HENCO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Anti-Tau Antibodies
- Publication number 20210238265
- Publication date Aug 5, 2021
- Biogen International Neuroscience GmbH
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR USE IN THE TREATMENT OF MICROGLIA-MEDIATE...
- Publication number 20210000807
- Publication date Jan 7, 2021
- NSC Therapeutics GmbH
- Abraham FISHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TDP-43 Specific Binding Molecules
- Publication number 20200017577
- Publication date Jan 16, 2020
- Biogen International Neuroscience GmbH
- Roger Nitsch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human Anti-SOD1 Antibodies
- Publication number 20190284302
- Publication date Sep 19, 2019
- NEURIMMUNE HOLDING AG
- Fabio Montrasio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20190263896
- Publication date Aug 29, 2019
- University of Zurich
- Roger NITSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Anti-Tau Antibodies
- Publication number 20190233506
- Publication date Aug 1, 2019
- Biogen International Neuroscience GmbH
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20190153082
- Publication date May 23, 2019
- University of Zurich
- Roger NITSCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human Anti-Alpha-Synuclein Antibodies
- Publication number 20180371065
- Publication date Dec 27, 2018
- BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
- Andreas Weihofen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Alpha Synuclein Binding Molecules
- Publication number 20180355027
- Publication date Dec 13, 2018
- BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
- Andreas Weihofen
- G01 - MEASURING TESTING
Information Patent Application
Method of Providing Disease-Specific Binding Molecules and Targets
- Publication number 20180134773
- Publication date May 17, 2018
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES...
- Publication number 20180110845
- Publication date Apr 26, 2018
- NEW YORK UNIVERSITY
- Karsten HENCO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Human Anti-Tau Antibodies
- Publication number 20180002409
- Publication date Jan 4, 2018
- BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
- Roger Nitsch
- G01 - MEASURING TESTING
Information Patent Application
NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES...
- Publication number 20170369592
- Publication date Dec 28, 2017
- Mabimmune Diagostics AG
- Chad BROKOPP
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20170283491
- Publication date Oct 5, 2017
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
Anti-Alpha Synuclein Binding Molecules
- Publication number 20170233463
- Publication date Aug 17, 2017
- BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
- Andreas Weihofen
- G01 - MEASURING TESTING
Information Patent Application
TDP-43 Specific Binding Molecules
- Publication number 20170152308
- Publication date Jun 1, 2017
- BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
- Roger Nitsch
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES...
- Publication number 20160354451
- Publication date Dec 8, 2016
- NEW YORK UNIVERSITY
- Karsten Henco
- G01 - MEASURING TESTING
Information Patent Application
Method of Providing Disease-Specific Binding Molecules and Targets
- Publication number 20160289310
- Publication date Oct 6, 2016
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES
- Publication number 20160244515
- Publication date Aug 25, 2016
- BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
- Andreas Weihofen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human Anti-SOD1 Antibodies
- Publication number 20160168267
- Publication date Jun 16, 2016
- NEURIMMUNE HOLDING AG
- Fabio Montrasio
- G01 - MEASURING TESTING
Information Patent Application
HUMAN ANTI-TAU ANTIBODIES
- Publication number 20150252102
- Publication date Sep 10, 2015
- University of Zurich
- ROGER NITSCH
- G01 - MEASURING TESTING
Information Patent Application
HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES
- Publication number 20150232542
- Publication date Aug 20, 2015
- BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH
- Andreas WEIHOFEN
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20150147343
- Publication date May 28, 2015
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
Anti-Alpha Synuclein Binding Molecules
- Publication number 20140369940
- Publication date Dec 18, 2014
- University of Zurich
- Andreas Weihofen
- G01 - MEASURING TESTING

Roger Nitsch

Person

Patents Grantslast 30 patents

Human anti-SOD1 antibodies

TDP-43 specific binding molecules

Method of providing patient specific immune response in amyloidoses...

Human anti-alpha-synuclein antibodies

Human anti-SOD1 antibodies

Anti-alpha synuclein binding molecules

TDP-43 specific binding molecules

Method of providing disease-specific binding molecules and targets

Methods of treating Alzheimer's disease

Anti-alpha synuclein binding molecules

Human anti-alpha-synuclein antibodies

Method of providing disease-specific binding molecules and targets

Method of providing disease-specific binding molecules and targets

Human anti-tau antibodies

TDP-43 specific binding molecules

Anti-α synuclein binding molecules

Method of providing patient specific immune response in amyloidoses...

Human anti-SOD1 antibodies

Humanized antibodies against the beta-amyloid peptide

Human anti-alpha-synuclein antibodies

Human anti-tau antibodies

Method of providing disease-specific binding molecules and targets

Monoclonal human tumor-specific antibody

Humanized antibodies against the β-amyloid peptide

Transgenic animal model for alzheimer's disease

Inducing neurofibrillary tangles in transgenic mice expressing a mu...

Muscarinic M1 agonist as an inhibitor of beta-amyloid (A&#x03B2;40...

Patents Applicationslast 30 patents

Human Anti-SOD1 Antibodies

HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVI...

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

ANTI-BETA-AMYLOID ANTIBODY FOR TREATING ALZHEIMER'S DISEASE

Human Anti-SOD1 Antibodies

METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES...

Human Anti-Tau Antibodies

COMPOUNDS AND METHODS FOR USE IN THE TREATMENT OF MICROGLIA-MEDIATE...

TDP-43 Specific Binding Molecules

Human Anti-SOD1 Antibodies

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Human Anti-Tau Antibodies

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Human Anti-Alpha-Synuclein Antibodies

Anti-Alpha Synuclein Binding Molecules

Method of Providing Disease-Specific Binding Molecules and Targets

METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES...

Human Anti-Tau Antibodies

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES...

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Anti-Alpha Synuclein Binding Molecules

TDP-43 Specific Binding Molecules

METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES...

Method of Providing Disease-Specific Binding Molecules and Targets

HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES

Human Anti-SOD1 Antibodies

HUMAN ANTI-TAU ANTIBODIES

HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Anti-Alpha Synuclein Binding Molecules

Muscarinic M1 agonist as an inhibitor of beta-amyloid (Aβ40...